S. GÜVEN Et Al. , "The Role of Fibrinolytic and Antifibrinolytic Activities in the Pathophysiology of HELLP Syndrome," HYPERTENSION IN PREGNANCY , vol.30, no.3, pp.275-286, 2011
GÜVEN, S. Et Al. 2011. The Role of Fibrinolytic and Antifibrinolytic Activities in the Pathophysiology of HELLP Syndrome. HYPERTENSION IN PREGNANCY , vol.30, no.3 , 275-286.
GÜVEN, S., Sonmez, M., & KARAHAN, S. C., (2011). The Role of Fibrinolytic and Antifibrinolytic Activities in the Pathophysiology of HELLP Syndrome. HYPERTENSION IN PREGNANCY , vol.30, no.3, 275-286.
GÜVEN, SÜLEYMAN, MEHMET SÖNMEZ, And SÜLEYMAN CANER KARAHAN. "The Role of Fibrinolytic and Antifibrinolytic Activities in the Pathophysiology of HELLP Syndrome," HYPERTENSION IN PREGNANCY , vol.30, no.3, 275-286, 2011
GÜVEN, SÜLEYMAN Et Al. "The Role of Fibrinolytic and Antifibrinolytic Activities in the Pathophysiology of HELLP Syndrome." HYPERTENSION IN PREGNANCY , vol.30, no.3, pp.275-286, 2011
GÜVEN, S. Sonmez, M. And KARAHAN, S. C. (2011) . "The Role of Fibrinolytic and Antifibrinolytic Activities in the Pathophysiology of HELLP Syndrome." HYPERTENSION IN PREGNANCY , vol.30, no.3, pp.275-286.
@article{article, author={SÜLEYMAN GÜVEN Et Al. }, title={The Role of Fibrinolytic and Antifibrinolytic Activities in the Pathophysiology of HELLP Syndrome}, journal={HYPERTENSION IN PREGNANCY}, year=2011, pages={275-286} }